Search

Your search keyword '"Ardanaz M"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Ardanaz M" Remove constraint Author: "Ardanaz M"
45 results on '"Ardanaz M"'

Search Results

1. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes

4. Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status

8. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes

10. What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools

11. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes

12. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome

13. BIALLELIC LOSSES OF 13Q DO NOT CONFER A POORER OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF 627 PATIENTS WITH ISOLATED 13Q DELETION

14. Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

15. Compliance with good practice in early breast cancer treatment in relation to total national health expenditure

16. 261 - What is the Outcome of Patients in the Intermediate IPSS-R Score Group? Spanish Approach for Better Stratification with Classical Tools

17. Efecto de la aplicación de tratamientos combinados de aditivos sobre la inhibición del pardeamiento enzimático en manzanas cv. Granny Smith mínimamente procesadas

19. Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

20. 297 Prognostic impact of severe thrombocytopenia in low risk myelodysplastic syndrome

21. Cytogenetic risk stratification in chronic myelomonocytic leukemia

28. Global surveillance of trends in cancer survival 2000-14 (concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

29. Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.

30. Methylation of CpG sites in BCL2 major breakpoint region and the increase of BCL2/JH translocation with aging.

31. Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia.

32. Transfusion dependence development and disease evolution in patients with MDS and del(5q) and without transfusion needs at diagnosis.

33. Methylation of the nonhomologous end joining repair pathway genes does not explain the increase of translocations with aging.

34. Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome.

35. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.

36. High mitochondrial DNA stability in B-cell chronic lymphocytic leukemia.

37. [Foetal/neonatal alloimmune thrombocytopenia. A review and case report].

38. Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.

39. Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma.

40. [National network of phenotyped erythrocytes: report on the current situation].

41. [Hemoglobin in blood donor selection].

44. [Homozygous Pelger-Huët anomaly. Apropos of a case].

Catalog

Books, media, physical & digital resources